[1]
2023. Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia. 95, 2 (Jun. 2023). DOI:https://doi.org/10.4081/aiua.2023.11509.